s20098 has been researched along with Long Sleeper Syndrome in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.70) | 18.2507 |
2000's | 10 (37.04) | 29.6817 |
2010's | 16 (59.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ballester, P; Belda, C; Fernández, E; Inda, MD; Javaloyes, A; Martínez, MJ; Morales, D; Muriel, J; Peiró, AM; Richdale, AL; Toral, N | 1 |
Deuschle, M; Fischer, EC; Zapp, AA | 1 |
Grosshans, M; Kiefer, F; Mutschler, J | 1 |
Frydman-Marom, A; Laudon, M | 1 |
Campanella, D; De Bartolomeis, A; De Berardis, D; Di Giannantonio, M; Di Nicola, M; Fornaro, M; Iasevoli, F; Martinotti, G; Mazza, M; Olivieri, L; Perna, G; Rapini, G; Serroni, N; Srinivasan, V; Tomasetti, C; Valchera, A | 1 |
Bucci, N; Perugi, G; Quaranta, G | 1 |
Avila, A; Bello, J; Caballol, N; Cardona, X; Leon, L; Martin-Baranera, M; Millet, P | 1 |
Dressman, MA; McLin, DE; Neubauer, DN; Williams, WP | 1 |
Cardinali, DP; Hardeland, R; Pandi-Perumal, SR; Poeggeler, B; Spence, DW; Srinivasan, V; Trakht, I | 1 |
Brown, GM; Cardinali, DP; Moscovitch, A; Pandi-Perumal, SR; Spence, DW; Srinivasan, V | 1 |
Popoli, M | 1 |
Kennedy, SH | 1 |
Kálmán, J; Kálmán, S | 1 |
Mendlewicz, J | 1 |
Owen, RT | 1 |
Guilleminault, C; Lemoine, P; Quera-Salva, MA | 1 |
Howland, RH | 1 |
Catalani, A; Cianci, S; Consolazione, M; Gabriel, C; Gaetani, S; Giovine, A; Laloux, C; Maccari, S; Mairesse, J; Malagodi, M; Mazzetta, A; Mennuni, G; Mocaër, E; Morley-Fletcher, S; Nicoletti, F; Silletti, V; van Camp, G; van Reeth, O; Zuena, AR | 1 |
Hauser, J; Lange, KM; Lange, KW; Tucha, L; Tucha, O | 1 |
Acuña-Castroviejo, D; Lauterbach, EC; Othman, Z; Srinivasan, V; Zakaria, R | 1 |
Ponsford, J; Rajaratnam, SM; Sinclair, KL | 1 |
Lam, RW | 1 |
Steinhilber, D | 1 |
Alvarez, E; Guilleminault, C; Lemoine, P | 1 |
Armstrong, SM; Guardiola-Lemaitre, B; McNulty, OM; Redman, JR | 1 |
17 review(s) available for s20098 and Long Sleeper Syndrome
Article | Year |
---|---|
Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.
Topics: Acetamides; Animals; Benzofurans; Clinical Trials as Topic; Cyclopropanes; Humans; Hypnotics and Sedatives; Indenes; Melatonin; Neurodegenerative Diseases; Receptors, Melatonin; Sleep Wake Disorders | 2014 |
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression.
Topics: Acetamides; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Fibromyalgia; Humans; Migraine Disorders; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Receptor, Serotonin, 5-HT2C; Schizophrenia; Sleep Wake Disorders | 2015 |
The use of agomelatine in OCD: effects on the motivational aspects and dysregulated circadian rhythms.
Topics: Acetamides; Animals; Bipolar Disorder; Chronobiology Disorders; Humans; Hypnotics and Sedatives; Motivation; Obsessive-Compulsive Disorder; Sleep Wake Disorders; Treatment Outcome | 2015 |
Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders.
Topics: Acetamides; Benzofurans; Circadian Rhythm; Cyclopropanes; Dietary Supplements; Humans; Receptors, Melatonin; Sleep Wake Disorders | 2016 |
Pathophysiology of depression: role of sleep and the melatonergic system.
Topics: Acetamides; Antidepressive Agents; Circadian Rhythm; Depression; Humans; Melatonin; Prevalence; Receptors, Melatonin; Sleep; Sleep Stages; Sleep Wake Disorders; Suprachiasmatic Nucleus; Wakefulness | 2009 |
Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine.
Topics: Acetamides; Animals; Brain; Chronobiology Disorders; Circadian Rhythm; Depressive Disorder, Major; Humans; Hypnotics and Sedatives; Melatonin; Sleep; Sleep Wake Disorders | 2009 |
Agomelatine: innovative pharmacological approach in depression.
Topics: Acetamides; Animals; Antidepressive Agents; Circadian Rhythm; Depressive Disorder, Major; Disease Models, Animal; Humans; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Serotonin 5-HT2 Receptor Antagonists; Sleep Wake Disorders | 2009 |
Agomelatine: efficacy at each phase of antidepressant treatment.
Topics: Acetamides; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder, Major; Humans; Psychiatric Status Rating Scales; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Recurrence; Serotonin 5-HT2 Receptor Antagonists; Sleep Wake Disorders | 2009 |
[Depression as chronobiological illness].
Topics: Acetamides; Affect; Biological Clocks; Chronotherapy; Circadian Rhythm; Depression; Depressive Disorder, Major; Humans; Hypnotics and Sedatives; Melatonin; Mood Disorders; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Sleep; Sleep Deprivation; Sleep Wake Disorders; Suprachiasmatic Nucleus | 2009 |
Sleep disturbances: core symptoms of major depressive disorder rather than associated or comorbid disorders.
Topics: Acetamides; Adrenergic alpha-Antagonists; Anticonvulsants; Antidepressive Agents; Comorbidity; Depressive Disorder, Major; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Secondary Prevention; Sleep Initiation and Maintenance Disorders; Sleep Stages; Sleep Wake Disorders; Sleep, REM | 2009 |
Agomelatine: a novel pharmacological approach to treating depression.
Topics: Acetamides; Animals; Antidepressive Agents; Anxiety; Depressive Disorder, Major; Drug Interactions; Humans; Melatonin; Secondary Prevention; Sleep Wake Disorders; Substance Withdrawal Syndrome | 2009 |
Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients.
Topics: Acetamides; Animals; Antidepressive Agents; Depressive Disorder, Major; Humans; Melatonin; Randomized Controlled Trials as Topic; Sleep Disorders, Circadian Rhythm; Sleep Wake Disorders | 2010 |
Agomelatine for major depressive episodes.
Topics: Acetamides; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Humans; Randomized Controlled Trials as Topic; Secondary Prevention; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Treatment Outcome | 2010 |
Circadian rhythms in obsessive-compulsive disorder.
Topics: Acetamides; Animals; Chronobiology Disorders; Hormones; Humans; Hypnotics and Sedatives; Obsessive-Compulsive Disorder; Sleep Wake Disorders | 2012 |
Agomelatine in depressive disorders: its novel mechanisms of action.
Topics: Acetamides; Animals; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Disease Models, Animal; Humans; Melatonin; Receptors, Melatonin; Sleep Wake Disorders | 2012 |
Sleep disturbances and depression: a challenge for antidepressants.
Topics: Acetamides; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder, Major; Drugs, Investigational; Electroencephalography; Humans; Sleep Wake Disorders; Treatment Outcome | 2006 |
[Melatonin, melatonin receptor agonists and tryptophan as sleep aids].
Topics: Acetamides; Animals; Antioxidants; Humans; Hypnotics and Sedatives; Indenes; Melatonin; Receptors, Melatonin; Sleep Wake Disorders; Tryptophan | 2007 |
2 trial(s) available for s20098 and Long Sleeper Syndrome
Article | Year |
---|---|
Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability.
Topics: Acetamides; Adult; Autism Spectrum Disorder; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Intellectual Disability; Male; Middle Aged; Sleep Wake Disorders; Time Factors; Young Adult | 2019 |
Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine.
Topics: Acetamides; Adolescent; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prevalence; Sleep; Sleep Wake Disorders; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2007 |
8 other study(ies) available for s20098 and Long Sleeper Syndrome
Article | Year |
---|---|
The effect of agomelatine and melatonin on sleep-related eating: a case report.
Topics: Acetamides; Central Nervous System Depressants; Depressive Disorder, Major; Female; Humans; Melatonin; Middle Aged; Night Eating Syndrome; Panic Disorder; Patient Compliance; Sleep Wake Disorders; Treatment Outcome; Weight Gain | 2017 |
Treatment of severe sleep disorder related to alcohol-dependence with high-dose agomelatine - a case report.
Topics: Acetamides; Aged; Alcoholism; Humans; Hypnotics and Sedatives; Male; Sleep Wake Disorders; Treatment Outcome | 2013 |
Agomelatine for Depression in Parkinson Disease: Additional Effect on Sleep and Motor Dysfunction.
Topics: Acetamides; Aged; Aged, 80 and over; Depression; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Sleep Wake Disorders | 2015 |
[Clinical experiences with agomelatine. The inner ear has to be synchronized again].
Topics: Acetamides; Antidepressive Agents; Circadian Rhythm; Controlled Clinical Trials as Topic; Depression; Ear, Inner; Humans; Hypnotics and Sedatives; Melatonin; Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Wake Disorders; Tranquilizing Agents | 2010 |
Publication bias and outcome reporting bias: agomelatine as a case example.
Topics: Acetamides; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Humans; Publication Bias; Sexual Dysfunction, Physiological; Sleep Wake Disorders | 2011 |
Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/wake cycle induced by prenatal restraint stress in adult rats.
Topics: Acetamides; Analysis of Variance; Animals; Animals, Newborn; Arousal; Autoradiography; Chronobiology Disorders; Disease Models, Animal; Drug Administration Schedule; Electroencephalography; Electromyography; Female; Hippocampus; Hypnotics and Sedatives; Male; Movement Disorders; Pregnancy; Prenatal Exposure Delayed Effects; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Melatonin; Restraint, Physical; Sleep Wake Disorders; Thiophenes | 2013 |
Actigraphic assessment of sleep disturbances following traumatic brain injury.
Topics: Acetamides; Actigraphy; Adolescent; Adult; Aged; Brain Injuries; Case-Control Studies; Fatigue; Female; Humans; Male; Middle Aged; Self Report; Sleep; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Young Adult | 2014 |
Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS).
Topics: Acetamides; Animals; Circadian Rhythm; Disease Models, Animal; Hypnotics and Sedatives; Male; Melatonin; Rats; Sleep Wake Disorders | 1993 |